Arkolith/Insider Trading/INDP/Form 4

Linscott Walt Addison

Chief Operating OfficerIndaptus Therapeutics, Inc. (INDP) · full profile →Form 4 · filed Apr 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 10, 2025Disposed to issuer(D)1K$0.06$680
Apr 10, 2025Disposed to issuer(D)3K$0.06$1500
Apr 10, 2025Disposed to issuer(D)1K$0.06$680
Apr 10, 2025Disposed to issuer(D)2K$0.06$1050
Apr 10, 2025Disposed to issuer(D)750$0.06$450
Apr 10, 2025Disposed to issuer(D)1K$0.06$750

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-003822) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML